There is heterogeneity in hepatocellular carcinoma (HCC) risk, both among patients with cirrhosis and those without cirrhosis. HCC risk calculators are needed that estimate HCC risk accurately in individual patients, including in precirrhotic liver disease and in specific conditions of high interest. HCC risk calculators would enable risk-based surveillance and could replace the current one-size-fits-all strategy.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Can Risk Stratification Models Be Used to Identify Patients without Cirrhosis Who Might Benefit from Hepatocellular Carcinoma Surveillance?

  • George N. Ioannou

摘要

There is heterogeneity in hepatocellular carcinoma (HCC) risk, both among patients with cirrhosis and those without cirrhosis. HCC risk calculators are needed that estimate HCC risk accurately in individual patients, including in precirrhotic liver disease and in specific conditions of high interest. HCC risk calculators would enable risk-based surveillance and could replace the current one-size-fits-all strategy.